PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
21951517 | HLA (HLA) | chorioamnionitis | NA | NA | NA | positive | |
positive maternal hla pra before 16 weeks of gestation and the temporal evolution of maternal hla pra are associated with the presence of chronic chorioamnionitis at the time of delivery. | |||||||
21951517 | HLA (HLA) | chorioamnionitis | NA | NA | NA | positive | |
furthermore, the findings herein indicate that subsets of fetuses are exposed to alloimmune hla antibodies for months, especially in cases with chronic chorioamnionitis. | |||||||
22972380 | HLA (HLA) | chorioamnionitis | NA | NA | rs9272346 | unclassified | |
previous investigations have implicated hla phenotypic variation in recurrent fetal loss and in chronic chorioamnionitis. | |||||||
12176885 | HLA MATCHED (HLA-MATCHED) | leukemia b cells | NA | heparin | NA | negation | |
transduction with aav/cd40l resulted in up-regulation of the costimulatory molecule cd80 not only on infected cll cells but also on noninfected bystander leukemia b cells, whereas this effect induced specific proliferation of hla-matched allogeneic t cells. | |||||||
14600138 | HLA-DRB1 (HLA-DRB1) | parvovirus b19 infection | NA | NA | NA | only_studied | |
all of these four patients carried at least one of the hla-drb1 alleles, which have been associated with symptomatic parvovirus b19 infection. | |||||||
16775358 | HLA-A*24 | parvovirus b19 infection | NA | NA | NA | unclassified | |
a highly restricted t-cell receptor dominates the cd8+ t-cell response to parvovirus b19 infection in hla-a*2402-positive individuals. | |||||||
16775358 | HLA-A*24 | parvovirus b19 infections | NA | NA | NA | unclassified | |
six of seven hla-a*2402-positive individuals with acute parvovirus b19 infections made vigorous cd8-positive cytotoxic t-cell (ctl) responses to the viral epitope fytpladqf. | |||||||
23824566 | HLA (HLA) | hantavirus infection | NA | retinoic | NA | unclassified | |
upon hantavirus infection of various human and primate cell lines, we observed transactivation of promoters controlling classical hla molecules. | |||||||
29039978 | HLA (HLA) | late-onset disorders | NA | NA | NA | unclassified | |
its indications have also been significantly extended to include common late-onset disorders and non-genetic conditions, such as testing for hla match. | |||||||
21734565 | HLA (HLA) | disease progressions | NA | NA | NA | unclassified | |
genetic and functional data confirm the importance of kir-hla interactions and provide new understanding of the role of innate restriction factors in resistance to hiv-1 and disease progression.summarysingle-gene, genome-wide association and expression studies have permitted the identification of innate immune genes and their variants that contribute to protection from disease progression. |
Copyright 2024